PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

This study has been completed.

Study NCT00048230 Information provided by Millennium Pharmaceuticals, Inc.

First Received: October 28, 2002 Last Updated: July 12, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given